Elanco Animal Health (ELAN) Treasury Shares (2018 - 2025)
Elanco Animal Health (ELAN) reported Treasury Shares of $2.6 million for Q4 2025, up 4.0% on a YoY basis from $2.5 million in Q4 2024, and up 4.0% sequentially from $2.5 million in Q4 2024.
Elanco Animal Health (ELAN) Treasury Shares (2018 - 2025) Analysis & Trends
Elanco Animal Health (ELAN) has 8 years of Treasury Shares data on file, last reported at $2.6 million in Q4 2025.
- For the quarter ending Q4 2025, Treasury Shares rose 4.0% year-over-year to $2.6 million; the trailing twelve-month figure through Dec 2025 stood at $2.6 million (up 4.0% YoY), and the FY2025 full-year result was $2.6 million, up 4.0% from the prior year.
- Treasury Shares rose to $2.6 million in Q4 2025, from $2.5 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $3.9 million in Q4 2023 to a low of $500000.0 in Q4 2022.
- A 5-year average of $2.1 million and a median of $2.5 million in 2024 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares slumped 50.0% in 2022 and soared 680.0% in 2023, its largest moves.
- Tracing ELAN's Treasury Shares over 5 years: stood at $1.0 million in 2021, then tumbled by 50.0% to $500000.0 in 2022, then soared by 680.0% to $3.9 million in 2023, then plunged by 35.9% to $2.5 million in 2024, then increased by 4.0% to $2.6 million in 2025.
- Business Quant data shows ELAN's Treasury Shares at $2.6 million in Q4 2025, $2.5 million in Q4 2024, and $3.9 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 59.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.60 Mn |
| Dec 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Dec 31, 2022 | 500,000.00 |
| Dec 31, 2022 | 500,000.00 |
| Dec 31, 2021 | 1.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Dec 31, 2020 | 1.20 Mn |
| Dec 31, 2020 | 1.20 Mn |
| Dec 31, 2019 | 800,000.00 |
| Dec 31, 2019 | 800,000.00 |
| Dec 31, 2018 | 200,000.00 |
| Dec 31, 2018 | 200,000.00 |